Glucocorticoid receptor explained
The glucocorticoid receptor (GR or GCR) also known as NR3C1 (nuclear receptor subfamily 3, group C, member 1) is the receptor to which cortisol and other glucocorticoids bind.
The GR is expressed in almost every cell in the body and regulates genes controlling the development, metabolism, and immune response. Because the receptor gene is expressed in several forms, it has many different (pleiotropic) effects in different parts of the body.
When glucocorticoids bind to GR, its primary mechanism of action is the regulation of gene transcription.[1] [2] The unbound receptor resides in the cytosol of the cell. After the receptor is bound to glucocorticoid, the receptor-glucocorticoid complex can take either of two paths. The activated GR complex up-regulates the expression of anti-inflammatory proteins in the nucleus or represses the expression of pro-inflammatory proteins in the cytosol (by preventing the translocation of other transcription factors from the cytosol into the nucleus).
In humans, the GR protein is encoded by gene which is located on chromosome 5 (5q31).[3] [4]
Structure
Like the other steroid receptors,[5] the glucocorticoid receptor is modular in structure[6] and contains the following domains (labeled A - F):
Ligand binding and response
In the absence of hormone, the glucocorticoid receptor (GR) resides in the cytosol complexed with a variety of proteins including heat shock protein 90 (hsp90), the heat shock protein 70 (hsp70) and the protein FKBP4 (FK506-binding protein 4).[7] The endogenous glucocorticoid hormone cortisol diffuses through the cell membrane into the cytoplasm and binds to the glucocorticoid receptor (GR) resulting in release of the heat shock proteins. The resulting activated form GR has two principal mechanisms of action, transactivation and transrepression,[8] [9] described below.
Transactivation
A direct mechanism of action involves homodimerization of the receptor, translocation via active transport into the nucleus, and binding to specific DNA response elements activating gene transcription. This mechanism of action is referred to as transactivation. The biological response depends on the cell type.
Transrepression
In the absence of activated GR, other transcription factors such as NF-κB or AP-1 themselves are able to transactivate target genes.[10] However activated GR can complex with these other transcription factors and prevent them from binding their target genes and hence repress the expression of genes that are normally upregulated by NF-κB or AP-1. This indirect mechanism of action is referred to as transrepression. GR transrepression via NF-κB and AP-1 is restricted only to certain cell types, and is not considered the universal mechanism for IκBα repression. [11] [12]
Clinical significance
The GR is abnormal in familial glucocorticoid resistance.[13]
In central nervous system structures, the glucocorticoid receptor is gaining interest as a novel representative of neuroendocrine integration, functioning as a major component of endocrine influence - specifically the stress response - upon the brain. The receptor is now implicated in both short and long-term adaptations seen in response to stressors and may be critical to the understanding of psychological disorders, including some or all subtypes of depression and post-traumatic stress disorder (PTSD).[14] Indeed, long-standing observations such as the mood dysregulations typical of Cushing's disease demonstrate the role of corticosteroids in regulating psychologic state; recent advances have demonstrated interactions with norepinephrine and serotonin at the neural level.[15] [16]
In preeclampsia (a hypertensive disorder commonly occurring in pregnant women), the level of a miRNA sequence possibly targeting this protein is elevated in the blood of the mother. Rather, the placenta elevates the level of exosomes containing this miRNA, which can result in inhibition of translation of molecule. Clinical significance of this information is not yet clarified.[17]
Agonists and antagonists
Dexamethasone and other corticosteroids are agonists, while mifepristone and ketoconazole are antagonists of the GR. Anabolic steroids also prevent cortisol from binding to the glucocorticoid receptor.
Interactions
Glucocorticoid receptor has been shown to interact with:
- BAG1,[18] [19]
- CEBPB,[20]
- CREBBP,[21]
- DAP3,[22]
- DAXX,[23]
- HSP90AA1,[22] [24] [25] [26] [27] [28] [29]
- HNRPU,[30]
- MED1,
- MED14,[31]
- Mineralocorticoid receptor,[32]
- NRIP1,[33] [34]
- NCOR1,[35] [36]
- NCOA1,[37]
- NCOA2,[38] [39]
- NCOA3,[38] [40]
- POU2F1,[41] [42]
- RANBP9,[43]
- RELA,[44] [45]
- SMAD3,[46] [47]
- SMARCD1,[40]
- SMARCA4[40] [48]
- STAT3,[49] [50]
- STAT5B,[51]
- Thioredoxin,[52]
- TRIM28,[53] and
- YWHAH.[54]
See also
Further reading
- Adcock IM, Ito K . Molecular mechanisms of corticosteroid actions . Monaldi Archives for Chest Disease = Archivio Monaldi per le Malattie del Torace . 55 . 3 . 256–266 . June 2000 . 10948677 .
- Chikanza IC . Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform . Annals of the New York Academy of Sciences . 966 . 1 . 39–48 . June 2002 . 12114257 . 10.1111/j.1749-6632.2002.tb04200.x . 85100496 . 2002NYASA.966...39C .
- Neeck G, Kluter A, Dotzlaw H, Eggert M . Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis . Annals of the New York Academy of Sciences . 966 . 1 . 491–495 . June 2002 . 12114309 . 10.1111/j.1749-6632.2002.tb04252.x . 5106644 . 2002NYASA.966..491N .
- Yudt MR, Cidlowski JA . The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene . Molecular Endocrinology . 16 . 8 . 1719–1726 . August 2002 . 12145329 . 10.1210/me.2002-0106 . free .
- Torrego A, Pujols L, Picado C . [Response to glucocorticoid treatment in asthma. The role of alpha and beta isoforms of the glucocorticoid receptor] . Archivos de Bronconeumologia . 38 . 9 . 436–440 . September 2002 . 12237016 . 10.1016/S0300-2896(02)75258-7 .
- Bray PJ, Cotton RG . Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms . Human Mutation . 21 . 6 . 557–568 . June 2003 . 12754700 . 10.1002/humu.10213 . 26191891 .
- Kino T, Pavlakis GN . Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1 . DNA and Cell Biology . 23 . 4 . 193–205 . April 2004 . 15142377 . 10.1089/104454904773819789 .
- Lu NZ, Cidlowski JA . The origin and functions of multiple human glucocorticoid receptor isoforms . Annals of the New York Academy of Sciences . 1024 . 1 . 102–123 . June 2004 . 15265776 . 10.1196/annals.1321.008 . 36368837 . 2004NYASA1024..102L .
- Kino T, Chrousos GP . Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome? . Annals of the New York Academy of Sciences . 1024 . 1 . 153–167 . June 2004 . 15265780 . 10.1196/annals.1321.013 . 23655886 . 2004NYASA1024..153K .
- Andersen JL, Planelles V . The role of Vpr in HIV-1 pathogenesis . Current HIV Research . 3 . 1 . 43–51 . January 2005 . 15638722 . 10.2174/1570162052772988 .
- Le Rouzic E, Benichou S . The Vpr protein from HIV-1: distinct roles along the viral life cycle . Retrovirology . 2 . 1 . 11 . February 2005 . 15725353 . 554975 . 10.1186/1742-4690-2-11 . free .
- Muthumani K, Choo AY, Premkumar A, Hwang DS, Thieu KP, Desai BM, Weiner DB . Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism . Cell Death and Differentiation . 12 . Suppl 1 . 962–970 . August 2005 . 15832179 . 10.1038/sj.cdd.4401583 . free .
- Zhou J, Cidlowski JA . The human glucocorticoid receptor: one gene, multiple proteins and diverse responses . Steroids . 70 . 5–7 . 407–417 . 2005 . 15862824 . 10.1016/j.steroids.2005.02.006 . 24272404 .
- Chrousos GP, Kino T . Intracellular glucocorticoid signaling: a formerly simple system turns stochastic . Science's STKE . 2005 . 304 . pe48 . October 2005 . 16204701 . 10.1126/stke.3042005pe48 . 23148406 .
- Plotkin LL, Labutin AL, Lebedev LV, Khanukov LA, Zelikson OS . [Balloon probe for the removal of emboli and thrombi] . Meditsinskaya Tekhnika . 3 . 42–43 . 1975 . 1152650 .
- Subramaniam M, Colvard D, Keeting PE, Rasmussen K, Riggs BL, Spelsberg TC . Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells . Journal of Cellular Biochemistry . 50 . 4 . 411–424 . December 1992 . 1469072 . 10.1002/jcb.240500410 . 21381419 .
- Scherrer LC, Pratt WB . Association of the transformed glucocorticoid receptor with a cytoskeletal protein complex . The Journal of Steroid Biochemistry and Molecular Biology . 41 . 3–8 . 719–721 . March 1992 . 1562545 . 10.1016/0960-0760(92)90411-B . free . 43672040 . 2027.42/30199 .
- Cadepond F, Gasc JM, Delahaye F, Jibard N, Schweizer-Groyer G, Segard-Maurel I, Evans R, Baulieu EE . 6 . Hormonal regulation of the nuclear localization signals of the human glucocorticosteroid receptor . Experimental Cell Research . 201 . 1 . 99–108 . July 1992 . 1612132 . 10.1016/0014-4827(92)90352-9 .
- Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP . 6 . Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance . The Journal of Clinical Investigation . 87 . 2 . 680–686 . February 1991 . 1704018 . 296359 . 10.1172/JCI115046 .
- Encío IJ, Detera-Wadleigh SD . The genomic structure of the human glucocorticoid receptor . The Journal of Biological Chemistry . 266 . 11 . 7182–7188 . April 1991 . 1707881 . 10.1016/S0021-9258(20)89627-6 . free .
External links
Notes and References
- Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA . 6 . International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors . Pharmacological Reviews . 58 . 4 . 782–797 . December 2006 . 17132855 . 10.1124/pr.58.4.9 . 28626145 . [Free full text]
- Rhen T, Cidlowski JA . Antiinflammatory action of glucocorticoids--new mechanisms for old drugs . The New England Journal of Medicine . 353 . 16 . 1711–1723 . October 2005 . 16236742 . 10.1056/NEJMra050541 . 5744727 .
- Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM . 6 . Primary structure and expression of a functional human glucocorticoid receptor cDNA . Nature . 318 . 6047 . 635–641 . December 1985 . 2867473 . 6165583 . 10.1038/318635a0 . 1985Natur.318..635H .
- Francke U, Foellmer BE . The glucocorticoid receptor gene is in 5q31-q32 [corrected] . Genomics . 4 . 4 . 610–612 . May 1989 . 2744768 . 10.1016/0888-7543(89)90287-5 .
- Kumar R, Thompson EB . The structure of the nuclear hormone receptors . Steroids . 64 . 5 . 310–319 . May 1999 . 10406480 . 10.1016/S0039-128X(99)00014-8 . 18333397 .
- Kumar R, Thompson EB . Gene regulation by the glucocorticoid receptor: structure:function relationship . The Journal of Steroid Biochemistry and Molecular Biology . 94 . 5 . 383–394 . April 2005 . 15876404 . 10.1016/j.jsbmb.2004.12.046 . 25315991 .
- Book: Pratt WB, Morishima Y, Murphy M, Harrell M . Molecular Chaperones in Health and Disease . Chaperoning of glucocorticoid receptors . 172 . . 111–138 . 2006 . 16610357 . 10.1007/3-540-29717-0_5 . 978-3-540-25875-9 . Handbook of Experimental Pharmacology . Springer .
- Buckingham JC . Glucocorticoids: exemplars of multi-tasking . British Journal of Pharmacology . 147 . Supplement 1 . S258–S268 . January 2006 . 16402112 . 1760726 . 10.1038/sj.bjp.0706456 .
- Hayashi R, Wada H, Ito K, Adcock IM . Effects of glucocorticoids on gene transcription . European Journal of Pharmacology . 500 . 1–3 . 51–62 . October 2004 . 15464020 . 10.1016/j.ejphar.2004.07.011 .
- Ray A, Prefontaine KE . Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor . Proceedings of the National Academy of Sciences of the United States of America . 91 . 2 . 752–756 . January 1994 . 8290595 . 43027 . 10.1073/pnas.91.2.752 . free . 1994PNAS...91..752R .
- Coutinho AE, Chapman KE . The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights . Molecular and Cellular Endocrinology . 335 . 1 . 2–13 . March 2011 . 20398732 . 3047790 . 10.1016/j.mce.2010.04.005 .
- Heck S, Bender K, Kullmann M, Göttlicher M, Herrlich P, Cato AC . I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor . The EMBO Journal . 16 . 15 . 4698–4707 . August 1997 . 9303314 . 1170096 . 10.1093/emboj/16.15.4698 .
- Mendonca BB, Leite MV, de Castro M, Kino T, Elias LL, Bachega TA, Arnhold IJ, Chrousos GP, Latronico AC . 6 . Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene . The Journal of Clinical Endocrinology and Metabolism . 87 . 4 . 1805–1809 . April 2002 . 11932321 . 10.1210/jcem.87.4.8379 . free .
- Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J . Neurobiology of depression: an integrated view of key findings . International Journal of Clinical Practice . 61 . 12 . 2030–2040 . December 2007 . 17944926 . 2228409 . 10.1111/j.1742-1241.2007.01602.x . [Free full text]
- Savitz J, Lucki I, Drevets WC . 5-HT(1A) receptor function in major depressive disorder . Progress in Neurobiology . 88 . 1 . 17–31 . May 2009 . 19428959 . 2736801 . 10.1016/j.pneurobio.2009.01.009 . [Free full text]
- Schechter DS, Moser DA, Paoloni-Giacobino A, Stenz L, Gex-Fabry M, Aue T, Adouan W, Cordero MI, Suardi F, Manini A, Sancho Rossignol A, Merminod G, Ansermet F, Dayer AG, Rusconi Serpa S . 6. Methylation of NR3C1 is related to maternal PTSD, parenting stress and maternal medial prefrontal cortical activity in response to child separation among mothers with histories of violence exposure . Front Psychol . 6 . 690 . 2015 . 26074844 . 4447998 . 10.3389/fpsyg.2015.00690 . free.
- Salomon C, Guanzon D, Scholz-Romero K, Longo S, Correa P, Illanes SE, Rice GE . Placental Exosomes as Early Biomarker of Preeclampsia: Potential Role of Exosomal MicroRNAs Across Gestation . The Journal of Clinical Endocrinology and Metabolism . 102 . 9 . 3182–3194 . September 2017 . 28531338 . 10.1210/jc.2017-00672 . free .
- Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC . RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis . The Journal of Biological Chemistry . 273 . 23 . 14620–14625 . June 1998 . 9603979 . 10.1074/jbc.273.23.14620 . free .
- Schneikert J, Hübner S, Langer G, Petri T, Jäättelä M, Reed J, Cato AC . Hsp70-RAP46 interaction in downregulation of DNA binding by glucocorticoid receptor . The EMBO Journal . 19 . 23 . 6508–6516 . December 2000 . 11101523 . 305849 . 10.1093/emboj/19.23.6508 .
- Boruk M, Savory JG, Haché RJ . AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor . Molecular Endocrinology . 12 . 11 . 1749–1763 . November 1998 . 9817600 . 10.1210/mend.12.11.0191 .
- Almlöf T, Wallberg AE, Gustafsson JA, Wright AP . Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors . Biochemistry . 37 . 26 . 9586–9594 . June 1998 . 9649342 . 10.1021/bi973029x .
- Hulkko SM, Wakui H, Zilliacus J . The pro-apoptotic protein death-associated protein 3 (DAP3) interacts with the glucocorticoid receptor and affects the receptor function . The Biochemical Journal . 349 . 3 . 885–893 . August 2000 . 10903152 . 1221218 . 10.1042/bj3490885 . 349 .
- Lin DY, Lai MZ, Ann DK, Shih HM . Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential . The Journal of Biological Chemistry . 278 . 18 . 15958–15965 . May 2003 . 12595526 . 10.1074/jbc.M300387200 . free.
- Jibard N, Meng X, Leclerc P, Rajkowski K, Fortin D, Schweizer-Groyer G, Catelli MG, Baulieu EE, Cadepond F . 6 . Delimitation of two regions in the 90-kDa heat shock protein (Hsp90) able to interact with the glucocorticosteroid receptor (GR) . Experimental Cell Research . 247 . 2 . 461–474 . March 1999 . 10066374 . 10.1006/excr.1998.4375 .
- Kanelakis KC, Shewach DS, Pratt WB . Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor.hsp90 heterocomplex assembly . The Journal of Biological Chemistry . 277 . 37 . 33698–33703 . September 2002 . 12093808 . 10.1074/jbc.M204164200 . free .
- Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Brönnegârd M, Wikström AC . Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor . The Journal of Biological Chemistry . 272 . 42 . 26659–26664 . October 1997 . 9334248 . 10.1074/jbc.272.42.26659 . free .
- de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, Chrousos GP . The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role . Molecular Medicine . 2 . 5 . 597–607 . September 1996 . 8898375 . 2230188 . 10.1007/BF03401643 .
- van den Berg JD, Smets LA, van Rooij H . Agonist-free transformation of the glucocorticoid receptor in human B-lymphoma cells . The Journal of Steroid Biochemistry and Molecular Biology . 57 . 3–4 . 239–249 . February 1996 . 8645634 . 10.1016/0960-0760(95)00271-5 . 20582144 .
- Stancato LF, Silverstein AM, Gitler C, Groner B, Pratt WB . Use of the thiol-specific derivatizing agent N-iodoacetyl-3-[125I]iodotyrosine to demonstrate conformational differences between the unbound and hsp90-bound glucocorticoid receptor hormone binding domain . The Journal of Biological Chemistry . 271 . 15 . 8831–8836 . April 1996 . 8621522 . 10.1074/jbc.271.15.8831 . free .
- Eggert M, Michel J, Schneider S, Bornfleth H, Baniahmad A, Fackelmayer FO, Schmidt S, Renkawitz R . 6 . The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U . The Journal of Biological Chemistry . 272 . 45 . 28471–28478 . November 1997 . 9353307 . 10.1074/jbc.272.45.28471 . free .
- Hittelman AB, Burakov D, Iñiguez-Lluhí JA, Freedman LP, Garabedian MJ . Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins . The EMBO Journal . 18 . 19 . 5380–5388 . October 1999 . 10508170 . 1171607 . 10.1093/emboj/18.19.5380 .
- Savory JG, Préfontaine GG, Lamprecht C, Liao M, Walther RF, Lefebvre YA, Haché RJ . Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces . Molecular and Cellular Biology . 21 . 3 . 781–793 . February 2001 . 11154266 . 86670 . 10.1128/MCB.21.3.781-793.2001 .
- Tazawa H, Osman W, Shoji Y, Treuter E, Gustafsson JA, Zilliacus J . Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140 . Molecular and Cellular Biology . 23 . 12 . 4187–4198 . June 2003 . 12773562 . 156128 . 10.1128/MCB.23.12.4187-4198.2003 .
- Subramaniam N, Treuter E, Okret S . Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids . The Journal of Biological Chemistry . 274 . 25 . 18121–18127 . June 1999 . 10364267 . 10.1074/jbc.274.25.18121 . free .
- Stevens A, Garside H, Berry A, Waters C, White A, Ray D . Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735 . Molecular Endocrinology . 17 . 5 . 845–859 . May 2003 . 12569182 . 10.1210/me.2002-0320 . free .
- Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R . RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding . The Journal of Biological Chemistry . 277 . 29 . 26238–26243 . July 2002 . 12011091 . 10.1074/jbc.M203268200 . free .
- Kucera T, Waltner-Law M, Scott DK, Prasad R, Granner DK . A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1 . The Journal of Biological Chemistry . 277 . 29 . 26098–26102 . July 2002 . 12118039 . 10.1074/jbc.M204013200 . free .
- Zilliacus J, Holter E, Wakui H, Tazawa H, Treuter E, Gustafsson JA . Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140 . Molecular Endocrinology . 15 . 4 . 501–511 . April 2001 . 11266503 . 10.1210/mend.15.4.0624 . free .
- Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE . 6 . Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition . Cell . 110 . 1 . 93–105 . July 2002 . 12151000 . 10.1016/S0092-8674(02)00817-6 . 6955342 . free .
- Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK . BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation . Molecular and Cellular Biology . 23 . 17 . 6210–6220 . September 2003 . 12917342 . 180928 . 10.1128/MCB.23.17.6210-6220.2003 .
- Préfontaine GG, Walther R, Giffin W, Lemieux ME, Pope L, Haché RJ . Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter . The Journal of Biological Chemistry . 274 . 38 . 26713–26719 . September 1999 . 10480874 . 10.1074/jbc.274.38.26713 . free .
- Préfontaine GG, Lemieux ME, Giffin W, Schild-Poulter C, Pope L, LaCasse E, Walker P, Haché RJ . 6 . Recruitment of octamer transcription factors to DNA by glucocorticoid receptor . Molecular and Cellular Biology . 18 . 6 . 3416–3430 . June 1998 . 9584182 . 108923 . 10.1128/MCB.18.6.3416 .
- Rao MA, Cheng H, Quayle AN, Nishitani H, Nelson CC, Rennie PS . RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor . The Journal of Biological Chemistry . 277 . 50 . 48020–48027 . December 2002 . 12361945 . 10.1074/jbc.M209741200 . free .
- Nissen RM, Yamamoto KR . The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain . Genes & Development . 14 . 18 . 2314–2329 . September 2000 . 10995388 . 316928 . 10.1101/gad.827900 .
- Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT . 6 . Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids . Molecular Endocrinology . 9 . 4 . 401–412 . April 1995 . 7659084 . 10.1210/mend.9.4.7659084 . 28680611 . free .
- Li G, Wang S, Gelehrter TD . Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action . The Journal of Biological Chemistry . 278 . 43 . 41779–41788 . October 2003 . 12902338 . 10.1074/jbc.M305350200 . 950035 . 10.1.1.631.7318 . free .
- Song CZ, Tian X, Gelehrter TD . Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3 . Proceedings of the National Academy of Sciences of the United States of America . 96 . 21 . 11776–11781 . October 1999 . 10518526 . 18362 . 10.1073/pnas.96.21.11776 . free . 1999PNAS...9611776S .
- Wallberg AE, Neely KE, Hassan AH, Gustafsson JA, Workman JL, Wright AP . Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain . Molecular and Cellular Biology . 20 . 6 . 2004–2013 . March 2000 . 10688647 . 110817 . 10.1128/MCB.20.6.2004-2013.2000 .
- Lerner L, Henriksen MA, Zhang X, Darnell JE . STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene . Genes & Development . 17 . 20 . 2564–2577 . October 2003 . 14522952 . 218150 . 10.1101/gad.1135003 .
- Zhang Z, Jones S, Hagood JS, Fuentes NL, Fuller GM . STAT3 acts as a co-activator of glucocorticoid receptor signaling . The Journal of Biological Chemistry . 272 . 49 . 30607–30610 . December 1997 . 9388192 . 10.1074/jbc.272.49.30607 . free .
- Stöcklin E, Wissler M, Gouilleux F, Groner B . Functional interactions between Stat5 and the glucocorticoid receptor . Nature . 383 . 6602 . 726–728 . October 1996 . 8878484 . 10.1038/383726a0 . 4356272 . 1996Natur.383..726S .
- Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, Tanaka H . Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function . The Journal of Biological Chemistry . 274 . 5 . 3182–3188 . January 1999 . 9915858 . 10.1074/jbc.274.5.3182 . free .
- Chang CJ, Chen YL, Lee SC . Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression . Molecular and Cellular Biology . 18 . 10 . 5880–5887 . October 1998 . 9742105 . 109174 . 10.1128/mcb.18.10.5880 .
- Wakui H, Wright AP, Gustafsson J, Zilliacus J . Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein . The Journal of Biological Chemistry . 272 . 13 . 8153–8156 . March 1997 . 9079630 . 10.1074/jbc.272.13.8153 . free .